Concurrently, Moody’s assigned its “A1” rating to BHSF’s proposed $794 million series 2017 revenue bonds.
The downgrade is a result of BHSF’s constrained operations despite efforts to mitigate the weakening operating trajectory. In addition, Moody’s attributed the downgrade to the heath system’s modest revenue growth, lower reimbursements and recent acquisition of Boynton Beach, Fla.-based Bethesda Healthcare System. Moody’s also acknowledged BHSF’s strong market position, large geographic footprint, solid liquidity metrics and limited debt structure risk.
The outlook remains negative, reflecting Moody’s expectation that the health system will continue to see operating challenges in fiscal year 2018.
More articles on healthcare finance:
12 recent hospital, health system outlook and credit rating actions
Partners HealthCare turns around worst financial loss to a profit in FY 2017
10 grants, donations to healthcare organizations in November
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
